市場調查報告書
商品編碼
1609826
2024-2032 年日本輔助生殖技術市場報告(按產品、類型(體外受精、人工授精)、最終用途和地區)Japan Assisted Reproductive Technology Market Report by Product, Type (In-Vitro Fertilization, Artificial Insemination), End Use, and Region 2024-2032 |
2023年日本輔助生殖技術市場規模達32.941IMARC Group美元。日本不孕症的盛行率不斷上升、政府採取的支持措施、輔助生殖技術的最新技術進步以及社會對不孕症治療的認知和接受度不斷提高,是推動市場發展的一些關鍵因素。
輔助生殖技術(ART)是指主要用於解決不孕症的醫療程序。它包括多種方法,例如體外受精 (IVF)、胞漿內單一精子注射 (ICSI)、配子或胚胎冷凍保存以及生育藥物。 ART 具有多種功能,例如能夠繞過受精的生理障礙、提高配子品質或保持生育力。它由醫學專業知識、先進的實驗室、法律框架和道德治理組成。 ART 被不孕夫婦、單身人士以及渴望為人父母的男女同性戀群體廣泛使用。它也可應用於遺傳性疾病預防、家庭平衡、代孕便利性和癌症患者的生育力保存。 ART 提供了更高的受孕機會、控制時間、篩檢遺傳疾病的可能性以及增加對生育能力的了解。除此之外,它還提供了幾個優點,例如多次懷孕嘗試的選擇以及允許同性伴侶或單親父母懷孕。
由於生活方式的改變和老年人口的增加,日本不孕症的盛行率日益增加,這是推動市場成長的關鍵因素之一。此外,政府推出的支持措施,例如補貼 ART 程序以鼓勵夫妻尋求治療,正在推動市場成長。除此之外,ART 的最新技術進步提高了成功率,從而促進了其採用,從而促進了市場的成長。此外,人們對不孕症治療的認知和社會接受度不斷提高,也促進了市場的成長。此外,監管框架的不斷完善為潛在患者提供了安全保證,正在推動市場成長。除此之外,日本可支配收入的增加,使更多的人能夠負擔得起通常昂貴的治療方法,例如抗逆轉錄病毒治療,這也推動了市場的成長。此外,主要參與者不斷增加對研究和創新的投資,以開發有效的不孕症治療方案,這對市場成長產生了積極影響。同時,日本和國際生育診所之間不斷加強的合作,以擴大獲得最佳實踐和先進治療的機會,並正在支持市場的成長。與此一致的是,日本文化中日益成長的社會壓力和對創建家庭的渴望正在推動市場的成長。此外,生育旅遊的出現,讓人們可以前往日本尋求高品質的輔助生殖服務,也刺激了市場的成長。此外,ART 服務擴展到更廣泛的人群,包括老年婦女和單身人士,這開闢了新的細分市場,正在加速市場成長。除此之外,基因篩檢技術的最新進展使 ART 更安全、更可靠,從而加強了全國市場的成長。
市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外,也提供了所有主要公司的詳細資料。
Japan assisted reproductive technology market size reached US$ 3,294.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,056.1 Million by 2032, exhibiting a growth rate (CAGR) of 7.00% during 2024-2032. The increasing prevalence of infertility in Japan, introduction of supportive measures by the government, recent technological advancements in ART, and rising awareness and societal acceptance of infertility treatment represent some of the key factors driving the market.
Assisted reproductive technology (ART) refers to medical procedures used primarily to address infertility. It includes a variety of methodologies, such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and fertility medication. ART possesses several features, like the ability to bypass physiological hurdles to fertilization, enhance gamete quality, or preserve fertility. It is comprised of medical expertise, sophisticated laboratories, legal frameworks, and ethical governance. ART is widely used by infertile couples, single individuals, and the lesbian and gay community desiring parenthood. It also finds applications in genetic disorder prevention, family balancing, surrogacy facilitation, and fertility preservation for cancer patients. ART offers a higher chance of conception, control over timing, the possibility of screening for genetic diseases, and increased knowledge about one's fertility. In addition to this, it provides several advantages, such as options for multiple pregnancy attempts and allowing same-sex couples or single parents to conceive.
The increasing prevalence of infertility in Japan due to lifestyle changes and the rising geriatric population represents one of the key factors propelling the market growth. Additionally, the introduction of supportive measures by the government, such as subsidizing ART procedures to encourage couples to seek treatment, is boosting the market growth. Besides this, recent technological advancements in ART that are enhancing success rates, thus boosting its adoption, are catalyzing the market growth. Furthermore, the rising awareness and social acceptance of infertility treatments are contributing to the market growth. In addition, the ongoing improvements in the regulatory framework, which provide safety assurances to potential patients, are driving the market growth. Apart from this, the increasing disposable incomes in Japan, allowing more individuals to afford often expensive treatments, such as ART, is bolstering the market growth. Moreover, the escalating investment in research and innovation by key players to develop effective treatment options for infertility is positively influencing the market growth. Along with this, the rising collaborations between Japanese and international fertility clinics to expand access to best practices and advanced treatments are supporting the market growth. In line with this, the increasing societal pressure and desire for family creation in Japan's culture is fueling the market growth. Additionally, the emergence of fertility tourism, allowing people to visit Japan for high-quality ART services, is stimulating the market growth. Furthermore, the extension of ART services to a broader demographic, including older women and single individuals, which is opening new segments, is accelerating the market growth. Besides this, recent advancements in genetic screening technologies that are making ART safer and more reliable are strengthening the market growth across the country.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.